#United States #New York #Class Action #Investment Fraud #Geron Corporation

Geron Corporation Shareholders Alert: Class Action Lawsuit Reminder

Recently, The Gross Law Firm issued an important notice aimed at investors of Geron Corporation (NASDAQ: GERN), highlighting a key opportunity for shareholders who may have been affected by the company's unrealized expectations. The notice pertains to a pending class action lawsuit with a significant deadline looming on May 12, 2025. This lawsuit may have substantial implications for individuals who purchased shares during the defined class period.

Class Period Details

The class period is defined as starting from February 28, 2024, until February 25, 2025. During this timeframe, shareholders acquired stocks of GERN, which has witnessed fluctuations attributed to various factors concerning the expected launch and the market performance of the company’s drug, Rytelo (imetelstat). According to the allegations detailed in the pending complaint, Geron and its executives provided misleading assurances to investors regarding the anticipated success of Rytelo and the broader strategy targeting patients with unmet medical needs.

Allegations Against Geron Corporation

The complaint claims that the company allegedly presented a pessimistic picture of the growth trajectory for Rytelo, downplaying the risks associated with a stringent weekly monitoring requirement and competitive pressures. On February 26, 2025, the company disclosed fourth-quarter financial results, revealing that the growth in Rytelo had stalled. This announcement dramatically impacted its stock value, causing it to drop from $2.37 to $1.61 in a matter of just 24 hours—a staggering decline of approximately 32.07%.

Importance of Registering for the Class Action

Shareholders who bought Geron stock during this period are strongly encouraged to consider registering to participate in the class action. Registration will not only allow them to follow the developments of the case through a specialized monitoring system but also enable potentially affected investors to seek compensation for their losses due to the alleged misinformation. Importantly, being appointed as a lead plaintiff is not a prerequisite for pursuing a claim. Shareholders simply have to provide their relevant information to join the action.

Next Steps for Affected Investors

The urgency of this matter cannot be overstated. Investors should not delay in registering their information to ensure they are included in this class action lawsuit by the established deadline of May 12, 2025. It is imperative that affected shareholders claim their rightful opportunity to seek recovery promptly. For more information, stakeholders can use the link provided by The Gross Law Firm to register.

About The Gross Law Firm

The Gross Law Firm is a reputable class action law firm recognized nationally for its staunch advocacy for investor rights. They specialize in addressing grievances related to fraudulent activities, providing legal support to those who suffer from corporate misconduct. Their mission is to uphold responsible business practices and protect the interests of investors in an often turbulent financial landscape.

In conclusion, Geron Corporation shareholders who purchased stock during the specified timeframe should act swiftly to register for the impending class action lawsuit. Grappling with turbulence due to the company's recent financial disclosures and the impact on stock performance, now is the time for investors to secure their rights and participate in possible recovery avenues while facing a significant deadline ahead.